Delivery Order SPE2DB20D2104-SPE2DB25FMYPP
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,747.38 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ebyglss 250 mg/2 mL pen medication, with an ultimate completion date of September 2, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at approximately $2,977 to AmerisourceBergen Drug Corp for Ebygloss 250 mg/2 mL pen medication on August 4, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is structured as a child contract under a larger vehicle, leveraging the company's existing federal procurement relationship to supply...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Ebyglss 250 mg/2 mL pen (2 mL) with a ceiling value of $4,121.07. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,178.93 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ebyglss 250 mg/2 ml pen (2 ml). This firm fixed-price, competitively awarded contract involves a non-set-aside procurement and is scheduled for completion by July 22, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,860.57 to AmerisourceBergen Drug Corp for Ebglyss 250 mg/2 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $25,885.03 to AmerisourceBergen Drug Corp for Ebylass 250 mg/2 ml pen (2 ml), a pharmaceutical product for federal medical procurement. The contract, which was competitively awarded without set-aside designation, carries a firm fixed price structure and was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, with a ceiling value of $2,343.59. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at the contractor's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,240.75 to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded without set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $6,700.74 to AmerisourceBergen Drug Corp for EBGLYSS 250 MG/2 ML PEN 2ML, a pharmaceutical product for federal medical supply needs. The contract, awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYPPDelivery Order
The Defense Logistics Agency awarded a $2,747.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ebyglss 250 mg/2 mL pens (2 mL quantity) with an ultimate completion date of August 22, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement across the Defense Health System. As a child contract under the SPE2DX master vehicle, this delivery order exemplifies AmerisourceBergen's role in supplying pharmaceutical products to support military healthcare operations globally. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse medical supply requirements, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical program leverages AmerisourceBergen's capabilities to ensure reliable pharmaceutical availability for Defense Health Agency beneficiaries, U.S. Coast Guard, and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/21/25 |